186 related articles for article (PubMed ID: 10403275)
1. Lymphoma development in Sjögren's syndrome: novel p53 mutations.
Tapinos NI; Polihronis M; Moutsopoulos HM
Arthritis Rheum; 1999 Jul; 42(7):1466-72. PubMed ID: 10403275
[TBL] [Abstract][Full Text] [Related]
2. Detection of clonally expanded salivary gland lymphocytes in Sjögren's syndrome.
Freimark B; Fantozzi R; Bone R; Bordin G; Fox R
Arthritis Rheum; 1989 Jul; 32(7):859-69. PubMed ID: 2546568
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjögren's syndrome.
Tapinos NI; Polihronis M; Thyphronitis G; Moutsopoulos HM
Arthritis Rheum; 2002 Jan; 46(1):215-22. PubMed ID: 11817594
[TBL] [Abstract][Full Text] [Related]
4. "Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation.
Xanthou G; Polihronis M; Tzioufas AG; Paikos S; Sideras P; Moutsopoulos HM
Arthritis Rheum; 2001 Feb; 44(2):408-18. PubMed ID: 11229473
[TBL] [Abstract][Full Text] [Related]
5. [Sjögren's syndrome associated with non-Hodgkin's lymphoma].
Nagai K
Nihon Rinsho; 1995 Oct; 53(10):2574-9. PubMed ID: 8531376
[TBL] [Abstract][Full Text] [Related]
6. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
[TBL] [Abstract][Full Text] [Related]
7. Analysis of V(H)-D-J(H) gene transcripts in B cells infiltrating the salivary glands and lymph node tissues of patients with Sjögren's syndrome.
Gellrich S; Rutz S; Borkowski A; Golembowski S; Gromnica-Ihle E; Sterry W; Jahn S
Arthritis Rheum; 1999 Feb; 42(2):240-7. PubMed ID: 10025917
[TBL] [Abstract][Full Text] [Related]
8. c-myc mRNA expression in minor salivary glands of patients with Sjögren's syndrome.
Skopouli FN; Kousvelari EE; Mertz P; Jaffe ES; Fox PC; Moutsopoulos HM
J Rheumatol; 1992 May; 19(5):693-9. PubMed ID: 1613697
[TBL] [Abstract][Full Text] [Related]
9. Evidence for coxsackievirus infection in primary Sjögren's syndrome.
Triantafyllopoulou A; Tapinos N; Moutsopoulos HM
Arthritis Rheum; 2004 Sep; 50(9):2897-902. PubMed ID: 15457458
[TBL] [Abstract][Full Text] [Related]
10. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells.
Martin T; Weber JC; Levallois H; Labouret N; Soley A; Koenig S; Korganow AS; Pasquali JL
Arthritis Rheum; 2000 Apr; 43(4):908-16. PubMed ID: 10765938
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects.
Hjelmervik TO; Petersen K; Jonassen I; Jonsson R; Bolstad AI
Arthritis Rheum; 2005 May; 52(5):1534-44. PubMed ID: 15880807
[TBL] [Abstract][Full Text] [Related]
12. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
[TBL] [Abstract][Full Text] [Related]
13. Association between primary Sjögren's syndrome and non-Hodgkin's lymphoma.
Opriş D; Iosif CI; Predeţeanu D
Rom J Intern Med; 2004; 42(4):715-23. PubMed ID: 16366143
[TBL] [Abstract][Full Text] [Related]
14. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus study in malignant lymphoma in Sjögren's syndrome.
Hirose Y; Sugai S; Masaki Y; Ogawa Y; Takeshita S; Kin C; Ogawa N
Int J Hematol; 1999 Apr; 69(3):174-9. PubMed ID: 10222656
[TBL] [Abstract][Full Text] [Related]
16. Dissemination of a Sjögren's syndrome-associated extranodal marginal-zone B cell lymphoma: circulating lymphoma cells and invariant mutation pattern of nodal Ig heavy- and light-chain variable-region gene rearrangements.
Hansen A; Reiter K; Pruss A; Loddenkemper C; Kaufmann O; Jacobi AM; Scholze J; Lipsky PE; Dörner T
Arthritis Rheum; 2006 Jan; 54(1):127-37. PubMed ID: 16385504
[TBL] [Abstract][Full Text] [Related]
17. Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjögren's syndrome.
Ek M; Popovic K; Harris HE; Nauclér CS; Wahren-Herlenius M
Arthritis Rheum; 2006 Jul; 54(7):2289-94. PubMed ID: 16802368
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland epithelial cells: a new source of the immunoregulatory hormone adiponectin.
Katsiougiannis S; Kapsogeorgou EK; Manoussakis MN; Skopouli FN
Arthritis Rheum; 2006 Jul; 54(7):2295-9. PubMed ID: 16802369
[TBL] [Abstract][Full Text] [Related]
19. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
[TBL] [Abstract][Full Text] [Related]
20. TP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin's lymphoma.
Hosny G; Farahat N; Hainaut P
Cancer Lett; 2009 Mar; 275(2):234-9. PubMed ID: 19046801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
